印度发起750 Crore MAHA-MedTech任务, 为结核病、癌症和新生儿护理等负担得起的医疗技术创新提供资金。 India launches Rs 750 crore MAHA-MedTech Mission to fund affordable medical tech innovations for tuberculosis, cancer, and neonatal care.

Anusandhan国家研究基金会与ICMR和盖茨基金会一起发起了MAHA-MedTech任务,这是一项为期五年的为期750卢比的倡议,目的是推动印度的医疗技术创新。 The Anusandhan National Research Foundation, with ICMR and the Gates Foundation, has launched the MAHA-MedTech Mission, a five-year, Rs 750 crore initiative to boost India’s medical technology innovation. 它将为多达50个项目提供资金,向50卢比的50克朗提供5卢比的里程碑式赠款,支持开办企业、机构和医院。 It will fund up to 50 projects with milestone-based grants of Rs 5 crore to Rs 50 crore, supporting startups, institutions, and hospitals. 优先注重在治疗结核病、癌症和新生儿护理的装置、诊断、植入和软件方面进行负担得起的创新。 Priority is given to affordable innovations in devices, diagnostics, implants, and software addressing tuberculosis, cancer, and neonatal care. 特派团通过专利、监管、临床试验和辅导方案提供非财政支持。 The mission offers non-financial support through patent, regulatory, clinical trial, and mentorship programs. 概念说明应于11月7日前提交,全部提议将于2025年12月提交。 Concept notes are due by November 7, with full proposals to be submitted in December 2025.